Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Dalvit

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Proteins|March 29, 2006
Inhibition of protein-protein interactions: the discovery of druglike beta-catenin inhibitors by combining virtual and biophysical screeningJean-Yves Trosset, Claudio Dalvit, Stefan Knapp, et al.
Journal of Medicinal Chemistry|February 4, 2017
Structure-Based Library Design and Fragment Screening for the Identification of Reversible Complement Factor D Protease InhibitorsAnna Vulpetti, Stefan Randl, Simon Rüdisser, et al.
Nature Reviews. Drug Discovery|January 28, 2009
Perspectives on NMR in drug discovery: a technique comes of ageMaurizio Pellecchia, Ivano Bertini, David Cowburn, et al.
Bioorganic & Medicinal Chemistry|July 2, 2014
Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitorsElena Casale, Nadia Amboldi, Maria Gabriella Brasca, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Proteins|March 29, 2006
Inhibition of protein-protein interactions: the discovery of druglike beta-catenin inhibitors by combining virtual and biophysical screeningJean-Yves Trosset, Claudio Dalvit, Stefan Knapp, et al.
Journal of Medicinal Chemistry|February 4, 2017
Structure-Based Library Design and Fragment Screening for the Identification of Reversible Complement Factor D Protease InhibitorsAnna Vulpetti, Stefan Randl, Simon Rüdisser, et al.
Nature Reviews. Drug Discovery|January 28, 2009
Perspectives on NMR in drug discovery: a technique comes of ageMaurizio Pellecchia, Ivano Bertini, David Cowburn, et al.
Bioorganic & Medicinal Chemistry|July 2, 2014
Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitorsElena Casale, Nadia Amboldi, Maria Gabriella Brasca, et al.
Pageof 5